The Utility of Partogram in Management

August 23, 2025 updated by: Egymedicalpedia

The Utility of Partogram in Management of Active Labor in Primigravidae and Its Impact In Qena Governorate

The partograph serves as "early warning system" and it has shown to be effective in preventing prolonged labour, in reducing operative interventions and in improving the neonatal outcome.

"A picture is worth a thousand words". A partograph review if well recorded provides rapid and comprehensive information about progress of labour when compared with a review of detailed handwritten case sheets. Partograph is a Latin/Greek hybrid word synonymous with parturition recorded in a graphic form.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

labour is a natural physiological process characterized by progressive increase in the frequency, intensity and duration of uterine contractions, resulting in effacement and dilatation of the cervix with descent of the foetus through the birth canal. This physiological process may take time lead to pathological one and failure to recognize this would result in prolonged labour with the resultant increase in the intensity in the morbidity and mortality of both foetus and the mother.This leads to surgical intervention with further danger to both the mother and foetus. Hence, prolonged labour and obstructed labour must be prevented by timely and effective measures, so as to give the mother a safe and happy experience of labour and child birth. The safe mother hood initiative (SMI) emphasises that the monitoring of labour for early detection of dystocia is one of the most important approaches for reducing maternal and neonatal morbidity and mortality.

In this context, the partogram has been adopted by the WHO (World health Organization) to monitor labour in maternity clinics in developing countries as a simple managerial tool to prevent prolonged labour, obstructed labour and its sequelle. The paperless partograph refers to monitoring progress of labour and reaching to an accurate decision for intervention to ensure safe delivery.

The partograph, a graphic recording of progress of labour and salient features in the mother and foetus has been used to detect labour that is not progressing normally, to help in early decision on augmentation and termination of labour.

WHO partograph is a composite graphic representation of events that takes place in labour plotted against time in hours on a pre-printed paper. It consists of three parameters:

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Asyut, Egypt
        • Al-Azhar University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primigravida, 20 and 35 years old
  • Gestational age 37 - 41 weeks with vertex presentation
  • Singleton pregnancy
  • Spontaneous or induced labour
  • First stage of labour with cervical dilatation < than 7 cm.

Exclusion Criteria:

  • Abnormal presentation
  • Macrosomic baby
  • Contacted pelvis
  • Multifetal gestations
  • Antepartum haemorrhage
  • Cases with high risk pregnancy as Severe PIH, Severe anaemia and gestational diabetes mellitus.
  • Patient refused to enrolled in the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A: Uncomplicated Normal Labour
About 140 prime gravidae females delivered before or at alert line
to evaluate the utility of partogram in management and progress of active labor in Primigravidae.
Active Comparator: Group B: Complicated Normal Labour
About 40 prime gravidae females delivered between alert and action line
to evaluate the utility of partogram in management and progress of active labor in Primigravidae.
Active Comparator: Group C: Cesarean Section Labour
About 20 prime gravidae females delivered after action line
to evaluate the utility of partogram in management and progress of active labor in Primigravidae.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mode of Delivery
Time Frame: 24 hours
The mode of delivery was assessed by the condition of the mother and the fetus by BISHOP score (The Bishop score is a cervical assessment system used to predict the success of labor induction. This scoring system evaluates several clinical parameters of the cervix, including dilation, effacement, position, consistency, and the fetal head's station in the pelvis).
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Chair: Abd El-Aziz Galal El-Din El-Darwish, Professor, Al-Azhar University, Faculty of medicine, Assuit.
  • Study Director: Khaled Mohamed Ahmed M. Abdallah, Assist.Professor, Al-Azhar University, Faculty of medicine, Assuit.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

September 1, 2024

Study Completion (Actual)

September 10, 2024

Study Registration Dates

First Submitted

August 25, 2024

First Submitted That Met QC Criteria

August 27, 2024

First Posted (Actual)

August 28, 2024

Study Record Updates

Last Update Posted (Estimated)

August 29, 2025

Last Update Submitted That Met QC Criteria

August 23, 2025

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Manal Ahmed Mohamed

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Onset

Clinical Trials on Partogram

Subscribe